ArticleNucleic acids research2026
GlycoRNAdb: a database of glycoRNA sequences, structures, abundance, and glycan information across tissues and cell lines.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The 2026 Nucleic Acids Research database issue and the online molecular biology database collection.Nucleic acids research · 2026Article
- GlycoRNA in cancer immune regulation and progression: biological mechanisms and translational therapeutic prospects.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Glycosylated RNAs (glycoRNAs), recently discovered as cell surface molecules modified by complex N-glycans, represent a transformative frontier in RNA biology with emerging roles in immune regulation and intercellular communication. To address the lack of a dedicated resource, we developed GlycoRNAdb (http://www.glycornadb.com), the first comprehensive database integrating experimentally supported, specifically enriched glycoRNA sequences with associated glycosylation sites, secondary structures, expression profiles, and glycan composition from human and mouse tissues and cell lines. Data were curated from public datasets and processed via specialized pipelines to identify enriched glycoRNAs. The database contains 3379 curated entries, each annotated with sequence, structure (experimentally determined or R2DT-predicted), glycosylation sites, expression patterns, and detailed glycan information (composition, linkages, and tissue distribution). Built with a FAIR-compliant architecture, GlycoRNAdb offers advanced search, BLAST-based homology search, JBrowse-based genome browser, and interactive visualizations of structures, modification maps, heatmaps, and glycan chemistry. It enables exploration of cell-type-specific modification patterns, sequence-structure relationships, and modifications located proximal to glycosylation sites, such as acp³U, as demonstrated by case studies on snoRNAs and tRNAs. By unifying scattered glycoRNA data into a centralized, analytically rich platform, GlycoRNAdb serves as an indispensable resource to accelerate research into the biological functions and therapeutic potential of this novel class of RNA molecules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.